Agios Pharmaceuticals, Inc. (LON:0HB0)
33.74
+0.66 (1.99%)
At close: Jun 27, 2025
Agios Pharmaceuticals Employees
As of December 31, 2024, Agios Pharmaceuticals had 488 total employees, including 486 full-time and 2 part-time employees. The number of employees increased by 102 or 26.42% compared to the previous year.
Employees
488
Change (1Y)
102
Growth (1Y)
26.42%
Revenue / Employee
58.86K GBP
Profits / Employee
1.06M GBP
Market Cap
1.41B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
Agios Pharmaceuticals News
- 19 days ago - Agios Pharmaceuticals: A More Compelling Valuation - Seeking Alpha
- 21 days ago - Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders - Business Wire
- 4 weeks ago - Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025 - GlobeNewsWire
- 6 weeks ago - Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress - GlobeNewsWire
- 7 weeks ago - Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025 - GlobeNewsWire
- 2 months ago - Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025 - GlobeNewsWire
- 2 months ago - Agios Pharmaceuticals, Inc. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Agios pharmaceuticals outlines key catalysts for PYRUKYND pipeline in 2025 - Seeking Alpha